CN Stock MarketDetailed Quotes

300363 Porton Pharma Solutions

Watchlist

20.70
-0.50-2.36%

Noon Break Nov 8 11:30 CST

11.29BMarket Cap-28830P/E (TTM)

Porton Pharma Solutions Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Porton Pharma Solutions Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q2	674.364M / 1.118B	--
--	2024/Q1	677.718M / 653.000M	--
--	2023/Q4	630.414M / 621.000M	--
--	2023/Q3	698.257M / 796.000M	--
--	2023/Q2	960.944M / 1.256B	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q2674.364M / 1.118B--

--2024/Q1677.718M / 653.000M--

--2023/Q4630.414M / 621.000M--

--2023/Q3698.257M / 796.000M--

--2023/Q2960.944M / 1.256B--

Unlock Free Earnings Estimates

Open Account

Porton Pharma Solutions Earnings Reports

Boteng shares: 2024 third quarter report

Oct 25 00:00

Boteng shares: 2024 semi-annual report

Aug 28 00:00

Boteng Shares: 2024 Semi-Annual Report Summary

Aug 28 00:00

Porton Pharma Solutions: 2024 First Quarter Report

Apr 27 00:00

Analyst Rating

Updated: Nov 7, 2024

Strong Buy

Strong Buy
86.67%
Buy
13.33%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall